- 2018Skin cancer, a new, hope-inspiring treatment
In 2015, the Pierre Fabre Group signed an international partnership with Array BioPharma, an American biotech company based in Boulder, Colorado. Aim: to develop and market a targeted oncology therapy, combining two next-generation molecules. In late 2018, the European Commission granted marketing authorization for this new treatment for adult patients suffering from advanced BRAF-mutant melanoma.
- 1951
- 1959
- 1962
- 1965
- 1970
- 1974
- 1979
- 1990
- 1999
- 2005
- 2010
- 2013
- 2015
- 2018
